You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

recombinant Factor VIIa

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recombinant Factor VII for Intractable Postpartum Haemorrhage

Completed
  • Post Partum Hemorrhage
  • recombinant factor VIIa
  • Cairo, Egypt
    Doaaa Alaa
Mar 18, 2022

Healthy Trial in Groningen (Milvexian, 4-Factor Prothrombin Complex Concentrate (4F-PCC), Recombinant Human Factor VIIa

Recruiting
  • Healthy
  • Groningen, Netherlands
    PRA Health Sciences
Jan 3, 2023

Real-World Utilization and Effectiveness of SEVENFACT®

Not yet recruiting
  • Hemophilia
  • (no location specified)
Jun 6, 2023

Hemophilia Trial (Coagulation Factor VIIa (Recombinant))

Not yet recruiting
  • Hemophilia
  • Coagulation Factor VIIa (Recombinant)
  • (no location specified)
Jan 12, 2023

Intracerebral Hemorrhage Trial in Worldwide (Recombinant Activated Factor VII (rFVIIa), Placebo)

Recruiting
  • Intracerebral Hemorrhage
  • Recombinant Activated Factor VII (rFVIIa)
  • Placebo
  • Burlingame, California
  • +48 more
Jan 25, 2023

Hemophilia A With Inhibitors, Hemophilia B With Inhibitors Trial in Worldwide (Coagulation FVIIa (Recombinant))

Completed
Has Results
  • Hemophilia A With Inhibitors
  • Hemophilia B With Inhibitors
  • Coagulation FVIIa (Recombinant)
  • Aurora, Colorado
  • +8 more
Feb 24, 2022

Hemophilia A, Hemophilia B Trial in Worldwide (Recombinant Factor VIIa BI (rFVIIa BI))

Completed
Has Results
  • Hemophilia A
  • Hemophilia B
  • Recombinant Factor VIIa BI (rFVIIa BI)
  • Tampa, Florida
  • +15 more
Apr 14, 2021

Hemophilia Trial in Worldwide (Coagulation Factor VIIa (Recombinant))

Completed
Has Results
  • Hemophilia
  • Coagulation Factor VIIa (Recombinant)
  • Dallas, Texas
  • +8 more
Feb 24, 2022

Hemophilia A With Inhibitor, Hemophilia B With Inhibitor Trial in Tianjin (TQG203, TQG203/NovoSeven®)

Recruiting
  • Hemophilia A With Inhibitor
  • Hemophilia B With Inhibitor
  • Tianjin, Tianjin, China
    Hematology Hospital of Chinese Academy of Medical Sciences
Feb 22, 2021

Bleeding Disorder Trial in Charlottesville (Recombinant von Willebrand Factor)

Not yet recruiting
  • Bleeding Disorder
  • Recombinant von Willebrand Factor
  • Charlottesville, Virginia
    UVA Hospital
Nov 3, 2023

Hemophilia A, Hemophilia B Trial in United States (MOD-5014)

Completed
  • Hemophilia A
  • Hemophilia B
  • Duarte, California
  • +10 more
May 18, 2021

Acute Gout Trial in Nanchang (rhTNFR-Fc, Triamcinolone Acetonide)

Not yet recruiting
  • Acute Gout
  • Nanchang, Jiangxi, China
    Department of Rheumatology and Clinical Immunology, Jiangxi Prov
Jun 28, 2023

Von Willebrand Disease (VWD) Trial (Recombinant von Willebrand Factor (rVWF), ADVATE)

Not yet recruiting
  • Von Willebrand Disease (VWD)
  • Recombinant von Willebrand Factor (rVWF)
  • ADVATE
  • (no location specified)
Oct 14, 2022

Severe Hemophilia A Trial in China (FRSW117)

Not yet recruiting
  • Severe Hemophilia A
  • Beijing, China
  • +27 more
Nov 16, 2023

Hemophilia A With Inhibitor, Hemophilia B With Inhibitor Trial in United States (coagulation factor VIIa [recombinant]-jncw)

Recruiting
  • Hemophilia A With Inhibitor
  • Hemophilia B With Inhibitor
  • coagulation factor VIIa [recombinant]-jncw
  • Phoenix, Arizona
  • +23 more
Aug 10, 2022

A Prospective and Retrospective Interventional Study on

Recruiting
  • Severe Hemophilia A Without Inhibitor
  • serum biomarker.
  • Taipei, Neihu Dist., Taiwan
    Tri-Service General Hospital Hemophilia Care Center
Aug 10, 2023

Solid Tumor Trial (Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T), Tumor necrosis factor-thymosin alfa 1 recombinant

Completed
  • Solid Tumor
  • Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T)
  • Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T) and chemotherapy
  • (no location specified)
Jun 8, 2023

Hemophilia A, Hemophilia B Trial in China (Recombinant human activated coagulation factor VII for injection)

Recruiting
  • Hemophilia A
  • Hemophilia B
  • Recombinant human activated coagulation factor VII for injection
  • Chongqing, Chongqing, China
  • +8 more
Aug 2, 2022

Hemophilia A With Inhibitor, Hemophilia B With Inhibitor Trial in Worldwide (Coagulation Factor VIIa variant)

Completed
Has Results
  • Hemophilia A With Inhibitor
  • Hemophilia B With Inhibitor
  • Coagulation Factor VIIa variant
  • Yerevan, Armenia
  • +8 more
Sep 21, 2021

Lymphoma Trial in Changchun (PEG-rhG-CSF, RhG-CSF)

Not yet recruiting
  • Lymphoma
  • Changchun, Jilin, China
    The First Bethune Hospital of Jilin University
Apr 18, 2023

Severe Hemophilia A Trial in China (ADVATE, FRSW117)

Completed
  • Severe Hemophilia A
  • Guangzhou, Guangzhou, China
  • +3 more
Jun 27, 2022

Hemophilia A Trial in China (ADVATE, FRSW107)

Recruiting
  • Hemophilia A
  • Beijing, Beijing, China
  • +5 more
Jun 27, 2022

Granulocyte Colony-stimulating Factor, Stem Cell Mobilization Trial (PEG-rhG-CSF)

Not yet recruiting
  • Granulocyte Colony-stimulating Factor
  • Stem Cell Mobilization
  • (no location specified)
Jun 13, 2022

Advanced Solid Tumor, Refractory Tumor Trial in Suzhou (Radiotherapy, PD-1/PD-L1 inhibitor, Granulocyte-macrophage

Recruiting
  • Advanced Solid Tumor
  • Refractory Tumor
  • Radiotherapy
  • +4 more
  • Suzhou, China
    The Second Affiliated Hospital of SchoowUniversity
Sep 14, 2023

Von Willebrand Diseases, Postpartum Hemorrhage Trial in Pittsburgh (Recombinant Von Willebrand factor, Tranexamic Acid Injection

Recruiting
  • Von Willebrand Diseases
  • Postpartum Hemorrhage
  • Recombinant Von Willebrand factor
  • Tranexamic Acid Injection [Cyklokapron]
  • Pittsburgh, Pennsylvania
  • +1 more
Jul 5, 2022